Abstract:Jingxia Wang, 1, 2, &ast Qiangqiang Xiang, 1, 2, &ast Silan Gu, 1, &ast Yudan Gu, 3 Mingfei Yao, 1 Weixin Huang, 4, 5 Wang Gao, 4 Ling-Ling Tang 1, 2 1 State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, People's Republic of China; 2 Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, Hangzhou, People's Republic of China; 3 Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 4 Jinan Microecological Biomedicine Shandong Laboratory, Jinan, People's Republic of China; 5 Shaoxing Tongchuang Biotechnology Co., Ltd, Shaoxing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ling-Ling Tang, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, Hangzhou, People's Republic of China, Email Background: Antibiotics are the first line of treatment for infectious diseases. However, their overuse can increase the spread of drug-resistant bacteria. The present study analyzed the impact of different types of antibiotics on the gut microbiome and cytokines level of mice. Methods: A total of five groups of 8-week-old male BALB/c mice (n = 35) were treated with piperacillin-tazobactam (TZP), ceftriaxone (CRO), tigecycline (TGC), levofloxacin (LEV) or normal saline (Ctrl), respectively, for up to 4 weeks. Fecal samples were analyzed by bacterial 16S rRNA gene sequencing for bacterial identification. Blood samples were used for the determination of 23 serum cytokines using multiplex immunoassay. Results: Exposure to antibiotics was shown to affect the normal weight gain of mice. Significant changes in gut composition caused by TZP, CRO and TGC treatment included the decreased abundance of Bacteroidetes (p < 0.01), Muribaculaceae (p < 0.01) and Lachnospiraceae (p < 0.01), and the increased abundance of Proteobacteria (p < 0.05), Enterobacteriaceae (including Klebsiella and Enterobacter ) (p < 0.01) and Enterococcaceae (including Enterococcus ) (p < 0.01). After 4-week treatment, the TZP, CRO and LEV groups had significantly lower concentrations of several serum cytokines. Correlation analysis of the top 30 bacterial genera and cytokines showed that Enterococcus and Klebsiella were strongly positively correlated with tumor necrosis factor-α (TNF-α), interleukins (IL) IL-12p70 and IL-1β. Desulfovibrio, Candidatus Saccharimonas, norank_f__norank_o__Clostridia_UCG-014, Lactobacillus , and Roseburi a were strongly negatively correlated with these cytokines. Conclusion: This study demonstrates the effects of various antibiotics on the intestinal microflora and immune status of mice. Compared with TZP, CRO and TGC, LEV had minimal impact on the gut microbiota. In addition to TGC, long-term TZP, CRO and LEV intervention can lead to a decrease in serum cytokine levels, which may depend on the intestinal microflora, antibiotic used and the duration of treatment. Keywords: gut microbiota, piperacillin-tazobactam, ceftriaxone, tigecycline, levofloxacin, cytokine, immunity Since the discovery of penicillin by Alexander Fleming in 1928, antibiotics have been widely used to save millions of lives. 1 However, the overuse and misuse of antibiotics have become a worldwide problem. There is increasing concern that antibiotic exposure may result in short- and/or long-term non-beneficial consequences, including an increased risk of necrotizing enterocolitis, bronchial allergy and asthma, obesity and autoimmune diseases. 2–6 In recent years, disruption of the intestinal microbiota by antibiotics has received increasing attention. Some studies have demonstrated a direct link between antibiotic use and alterations in the intestinal microbiota. 7–10 Moreover, it was found that antibiotic inducing changes in the gut microbiota may affect normal immune function or immune status by disrupting metabolic homeostasis. 11–13 Among various antibiotics, the side effect of broad-spectrum antibiotics is easy to be depreciated as they are widely used in human and animal disease prevention and treatment. However, long-term high-dose application of broad-spectrum antibi -Abstract Truncated-

Clinically used broad-spectrum antibiotics compromise inflammatory monocyte-dependent antibacterial defense in the lung

Effect Of The Short-Term Use Of Fluoroquinolone And Beta-Lactam Antibiotics On Mouse Gut Microbiota

Effect of antibiotic gut microbiota disruption on LPS-induced acute lung inflammation

Impact of prophylactic and 'rescue pack' antibiotics on the airway microbiome in chronic lung disease

Association of Sputum Microbiome with Clinical Outcome of Initial Antibiotic Treatment in Hospitalized Patients with Acute Exacerbations of COPD.

Emergence of nosocomial associated opportunistic pathogens in the gut microbiome after antibiotic treatment

Integrative Transkingdom Analysis of the Gut Microbiome in Antibiotic Perturbation and Critical Illness

Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection

Antibiotic use during influenza infection augments lung eosinophils that impair immunity against secondary bacterial pneumonia

[Bacterial resistance and antimicrobial therapy in respiratory medicine and intensive care]

Antibiotic-induced spp. expansion in infants promotes early-life immune dysregulation and airway inflammation in mice

The microbiota protects against Pseudomonas aeruginosa pneumonia via γδ T cell-neutrophil axis in mice

Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides Difficile Infection in the Mouse Intestine.

Short- and Long-Term Effects of Different Antibiotics on the Gut Microbiota and Cytokines Level in Mice

Alterations in gut microbiota and inflammatory cytokines after administration of antibiotics in mice

Antibiotics create a shift from mutualism to competition in human gut communities with a longer-lasting impact on fungi than bacteria

Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice

Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases

Antibiotic Treatment Using Amoxicillin-Clavulanic Acid Impairs Gut Mycobiota Development Through Modification of the Bacterial Ecosystem

Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm

Gut Microbiota Contributes to Resistance Against Pneumococcal Pneumonia in Immunodeficient Rag-/- Mice